171 related articles for article (PubMed ID: 1515088)
1. Cysteine endopeptidases and their inhibitors in malignant progression of rat embryo fibroblasts.
Sloane BF; Rozhin J; Moin K; Ziegler G; Fong D; Muschel RJ
Biol Chem Hoppe Seyler; 1992 Jul; 373(7):589-94. PubMed ID: 1515088
[TBL] [Abstract][Full Text] [Related]
2. [Cathepsins L and B and their endogenous inhibitors in embryonal fibroblasts transformed by different genes].
Dilakian EA; Vinokurova SV; Zhurbitskaia VA; Komissarova EV; Topol' LZ; Kiselev FL; Solov'eva NI
Vopr Med Khim; 1998; 44(1):35-42. PubMed ID: 9575611
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells.
Chambers AF; Colella R; Denhardt DT; Wilson SM
Mol Carcinog; 1992; 5(3):238-45. PubMed ID: 1586450
[TBL] [Abstract][Full Text] [Related]
4. Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts.
Denhardt DT; Greenberg AH; Egan SE; Hamilton RT; Wright JA
Oncogene; 1987; 2(1):55-9. PubMed ID: 3438085
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic enzymes at various stages of oncogenic transformation of rat fibroblasts. I. Aspartyl and cysteine proteinases.
Solovyeva NI; Balayevskaya TO; Dilakyan EA; Zakamaldina-Zama TA; Pozdnev VF; Topol LZ; Kisseljov FL
Int J Cancer; 1995 Feb; 60(4):495-500. PubMed ID: 7829263
[TBL] [Abstract][Full Text] [Related]
6. [Cysteine proteinases at various stages of neoplastic transformation of rat fibroblasts].
Dilakian EA; Solov'eva NI; Topol' LZ
Vopr Med Khim; 1991; 37(6):36-9. PubMed ID: 1812612
[TBL] [Abstract][Full Text] [Related]
7. Expression of cathepsin L and its endogenous inhibitors in immortal and transformed fibroblasts.
Dilakyan EA; Zhurbitskaya VA; Vinokurova SV; Gureeva TA; Lubkova ON; Topol LZ; Kisseljov FL; Solovyeva NI
Clin Chim Acta; 2001 Jul; 309(1):37-43. PubMed ID: 11408004
[TBL] [Abstract][Full Text] [Related]
8. [Expression of cathepsins D and L during neoplastic transformation of fibroblasts].
Dilakian EA; Balaevskaia TO; Zakamaldina-Tsama TA; Topol' LZ; Solov'eva NI
Vopr Med Khim; 1994; 40(3):2-6. PubMed ID: 8079433
[TBL] [Abstract][Full Text] [Related]
9. Presence of activated ras correlates with increased cysteine proteinase activities in human colorectal carcinomas.
Kim K; Cai J; Shuja S; Kuo T; Murnane MJ
Int J Cancer; 1998 Aug; 79(4):324-33. PubMed ID: 9699522
[TBL] [Abstract][Full Text] [Related]
10. Glucose controls cathepsin expression in Ras-transformed fibroblasts.
Tournu C; Obled A; Roux MP; Deval C; Ferrara M; Béchet DM
Arch Biochem Biophys; 1998 Dec; 360(1):15-24. PubMed ID: 9826424
[TBL] [Abstract][Full Text] [Related]
11. Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells.
Kirschke H; Eerola R; Hopsu-Havu VK; Brömme D; Vuorio E
Eur J Cancer; 2000 Apr; 36(6):787-95. PubMed ID: 10762753
[TBL] [Abstract][Full Text] [Related]
12. Physical association of Ras and cathepsins B and L in the conditioned medium of v-Ha-ras-transformed NIH3T3 cells.
Hiwasa T; Kominami E
Biochem Biophys Res Commun; 1995 Nov; 216(3):828-34. PubMed ID: 7488200
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin B and L activities in isolated osteoclasts.
Rifkin BR; Vernillo AT; Kleckner AP; Auszmann JM; Rosenberg LR; Zimmerman M
Biochem Biophys Res Commun; 1991 Aug; 179(1):63-9. PubMed ID: 1883385
[TBL] [Abstract][Full Text] [Related]
14. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue.
Friedrich B; Jung K; Lein M; Türk I; Rudolph B; Hampel G; Schnorr D; Loening SA
Eur J Cancer; 1999 Jan; 35(1):138-44. PubMed ID: 10211102
[TBL] [Abstract][Full Text] [Related]
15. Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells.
Lemaire R; Huet G; Zerimech F; Grard G; Fontaine C; Duquesnoy B; Flipo RM
Br J Rheumatol; 1997 Jul; 36(7):735-43. PubMed ID: 9255106
[TBL] [Abstract][Full Text] [Related]
16. Sensitization to the lysosomal cell death pathway upon immortalization and transformation.
Fehrenbacher N; Gyrd-Hansen M; Poulsen B; Felbor U; Kallunki T; Boes M; Weber E; Leist M; Jäättelä M
Cancer Res; 2004 Aug; 64(15):5301-10. PubMed ID: 15289336
[TBL] [Abstract][Full Text] [Related]
17. Membrane-associated cathepsin L: a role in metastasis of melanomas.
Rozhin J; Wade RL; Honn KV; Sloane BF
Biochem Biophys Res Commun; 1989 Oct; 164(1):556-61. PubMed ID: 2803319
[TBL] [Abstract][Full Text] [Related]
18. IL-6/sIL-6R enhances cathepsin B and L production via caveolin-1-mediated JNK-AP-1 pathway in human gingival fibroblasts.
Yamaguchi T; Naruishi K; Arai H; Nishimura F; Takashiba S
J Cell Physiol; 2008 Nov; 217(2):423-32. PubMed ID: 18543249
[TBL] [Abstract][Full Text] [Related]
19. Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells.
Colella R; Casey SF
Biotech Histochem; 2003 Apr; 78(2):101-8. PubMed ID: 14533846
[TBL] [Abstract][Full Text] [Related]
20. Glucose regulates protein catabolism in ras-transformed fibroblasts through a lysosomal-dependent proteolytic pathway.
Tournu C; Obled A; Roux MP; Ferrara M; Omura S; Béchet DM
Biochem J; 2001 Jul; 357(Pt 1):255-61. PubMed ID: 11415457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
